Stacy L. Chin explains that SBIR foreign risk screening is now a core eligibility requirement for all applicants, not just a compliance detail. Every proposal gets assessed on ownership, investors, licensing, patents, employee ties, and other foreign relationships. Companies that document their foreign connections upfront will move through review faster than those that discover issues late.
If you remember one thing from this video, please make it this: the new foreign risk screening requirements in the SBIR program are no longer a niche compliance issue. They're actually becoming a core eligibility requirement for every applicant. Every application can be evaluated across multiple dimensions, including ownership, investors, licensing agreements, patent rights, employee affiliations, and other foreign relationships. The question no longer is, do you have foreign connections? But now rather the question is, can you clearly explain and document them? And so the startups that prepare early will move through this process much more smoothly than companies that discover these issues at the last minute.
Applying for NIH SBIR in Jan 5, 2027? You Should Be Starting NOW. Here's why...
How to Get Invited to Apply for $305K in NSF SBIR Funding || Step-by-Step Guide
